Skip to main content
padlock icon - secure page this page is secure

Free Content Concordance of actigraphy with polysomnography in children with and without attention‐deficit/hyperactivity disorder

Download Article:

You have access to the full text article on a website external to Ingenta Connect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

This study sought to: (1) compare actigraphy‐derived estimated sleep variables to the same variables based on the gold‐standard of sleep assessment, polysomnography; (2) examine whether the correlations between the measures differ between children with attention‐deficit/hyperactivity disorder and typically developing children; and (3) determine whether these correlations are altered when children with attention‐deficit/hyperactivity disorder are treated with medication. Participants (24 attention‐deficit/hyperactivity disorder; 24 typically developing), aged 6–12 years, completed a 1‐week baseline assessment of typical sleep and daytime functioning. Following the baseline week, participants in the attention‐deficit/hyperactivity disorder group completed a 4‐week blinded randomized control trial of methylphenidate hydrochloride, including a 2‐week placebo and 2‐week methylphenidate hydrochloride treatment period. At the end of each observation (typically developing: baseline; attention‐deficit/hyperactivity disorder: baseline, placebo and methylphenidate hydrochloride treatment), all participants were invited to a sleep research laboratory, where overnight polysomnography and actigraphy were recorded concurrently. Findings from intra‐class correlations and Bland–Altman plots were consistent. Actigraphy was found to provide good estimates (e.g. intra‐class correlations >0.61) of polysomnography results for sleep duration for all groups and conditions, as well as for sleep‐onset latency and sleep efficiency for the typically developing group and attention‐deficit/hyperactivity disorder group while on medication, but not for the attention‐deficit/hyperactivity disorder group during baseline or placebo. Based on the Bland–Altman plots, actigraphy tended to underestimate for sleep duration (8.6–18.5 min), sleep efficiency (5.6–9.3%) and sleep‐onset latency, except for attention‐deficit/hyperactivity disorder during placebo in which actigraphy overestimated (−2.1 to 6.3 min). The results of the current study highlight the importance of utilizing a multimodal approach to sleep assessment in children with attention‐deficit/hyperactivity disorder.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: sleep; sleep duration; sleep efficiency; sleep onset latency; stimulant medication

Document Type: Research Article

Publication date: October 1, 2016

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more